Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy

Cancer Research

Volumn 56, Issue 18, 1996, Pages 4087-4095

  Tjuvajev, Juri G ^a   Finn, Ronald ^a   Watanabe, Kyoichi ^a   Joshi, Revathi ^a   Oku, Takamitsu ^a   Kennedy, John ^a   Beattie, Bradley ^a   Koutcher, Jason ^a   Larson, Steven ^a   Blasberg, Ronald G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CANCER GROWTH; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS 1; IMAGE QUALITY; IMAGING; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; ANTIVIRAL AGENTS; ARABINOFURANOSYLURACIL; CARBON RADIOISOTOPES; CELL LINE; GAMMA CAMERAS; GANCICLOVIR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLIOMA; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, NUDE; SENSITIVITY AND SPECIFICITY; SIMPLEXVIRUS; THYMIDINE KINASE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 9544242826     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Clinical protocol list. Cancer Gene Ther., 2: 225-234, 1995.
2. Tjuvajev, J. G., Stackhammer, G , Desai, R., Uehara, H., Watanabe, Gansbacher, B., and Blasberg, R. G Imaging the expression of transfected genes in vivo. Cancer Res., 55: 6126-6132, 1995.
3. Wechsler, W., Ramadan, M. A., and Geister, A. Isogenic transplantation of ethylnitrosourea-induced tumors of the central and peripheral nervous system in two different inbred rat strains. Naturwissenschaften, 59: 474-478, 1972.
4. Moolten, F. L., and Wells, J. M. Curability of tumors bearing herpes thymidine kinase genes transfected by retroviral vectors J. Natl Cancer Inst., 82: 297-300, 1990.
5. Tjuvajev, J. G , Gansbacher, B., Desai, R., Beattie, B., Kaplitt, M., Matei, C., Koutcher, J , Gilboa, E , and Blasberg, R. RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-γ. Cancer Res., 55 1902-1910, 1995.
6. 131I]-iododeoxyuridine. J. Nucl. Med , 35: 1407-1417, 1994.
7. 123I]-Iododeoxyuridine (IUdR) SPECT imaging of brain tumors proliferative activity. Eur. J. Nucl. Med., 22(Suppl. 8): 868P, 1995.
8. 124I]-iododeoxyuridine imaging tumors proliferation J. Nucl. Med , 37(Suppl. 5) 53P, 1996.
9. Iwashina, T. Tovell, D R., Xu, L., Tyrrell, D. L., Knaus, E. E., and Wiebe, L. I. Synthesis and antiviral activity of IVFRU, a potential probe for the non-invasive diagnosis of herpes simplex encephalitis. Drug Des. Deliv., 3: 309-321, 1988
10. Chou, T. C., Kong, X. B., Fanucchi, M. P., Cheng, YC., Takahashi, K., Watanabe, K. A , and Fox, J J. Synthesis and biological effects of 2′-fluoro-5-ethyl-1-β-D-arabinofuranosyl-uracil. Antimicrob. Agents Chemother., 31 1355-1358, 1987
11. Balzanni, J., Morin, K. W., Knaus, E E , Wiebe, L. I., and De Clercq, E Novel (E)-5-(2-iodovinyl)-2′-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors Gene Ther., 2, 317-322, 1995.
12. Machida, H., Watanabe, Y., Kano, F , Sakata, S., Kumagai, M., and Yamaguchi, T. Deglycosylation of antiherpesviral 5-substituted arabinosyluracil derivatives by rat liver extract and enterobacteria cells. Biochem. Pharmacol., 49: 763-766, 1995
13. Chou, T-C., Feinberg, A., Grant, A. J., Vidal, P., Reichman, U., Watanabe, K. A., Fox, J. J., and Philips, F. S. Pharmacological disposition and metabolic fate of 2′-fluoro-5-iodo-1β-D-arabino-furanosyl-cytosine in mice and rats. Cancer Res., 41: 3336-3342, 1981.
14. 14C]-5-iodo-(2′-fluoro-2′-deoxy-1-β-D-arabino- furanosyl)-cytosine in immunosuppressed patients with herpesvirus infections. Antimicrob. Agents Chemother , 27: 733-738, 1985.
15. McKenzie, R., Fried, M W., Sallie, R., Conjeevaram, H , Di Bisceglie, A. M., Park, Y., Savarese, B., Kleiner, D , Tsokos, M., Luciano, C., Pruett, T , Stotka, J L , Straus, S. E., and Hoofnagle, J. H. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J. Med., 333: 1099-1105, 1995.
16. 82Br labelled 5-halo-1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl) uracils. Appl. Radiat. Isot., 37: 901-905, 1986.
17. Manning, F. J., and Swartz, M (eds.). Review of Fialuridine (FIAU) Clinical Trials, Institute of Medicine. Washington, DC: National Academy Press, 1995.